Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.625, 2011-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
INTEREST piqued with gefitinib in NSCLC
Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. :
Access to resources
Recommend
Gefitinib shows promise in NSCLC
Inpharma, Vol. 1, Iss. 1349, 2002-01 ,pp. :
Gefitinib sparks INTEREST as NSCLC treatment
Inpharma, Vol. 1, Iss. 1611, 2007-01 ,pp. :
EGFR mutations underlie the responsiveness of NSCLC to gefitinib
Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. :
Drugs, Vol. 62, Iss. 15, 2002-01 ,pp. :